{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:51:30Z","timestamp":1765057890153,"version":"3.40.4"},"reference-count":28,"publisher":"Scientific Scholar","content-domain":{"domain":["indianjnephrol.org"],"crossmark-restriction":true},"short-container-title":["IJN"],"abstract":"\nBackground<\/jats:title>\nAtypical hemolytic uremic syndrome (aHUS) is a severe thrombotic microangiopathy predominantly affecting the kidneys, often associated with complement dysregulation. This study is aimed to analyze the clinical characteristics, treatment outcomes, and long-term implications of aHUS in a resource-limited setting.<\/jats:p>\n<\/jats:sec>\n\nMaterials and Methods<\/jats:title>\nA retrospective observational study conducted at an institute between January 2016 and December 2022 included all patients with aHUS, excluding secondary causes and renal transplant recipients. Demographic profiles, clinical features, laboratory parameters, treatment modalities (immunosuppression and plasma exchange), and outcomes were collected. Anticomplement Factor H (anti-CFH) antibody, complement levels, and genetic mutation analysis were performed to ascertain etiological factors. The patient and renal outcomes of anti-CFH positive and negative patients on long-term follow-up were compared.<\/jats:p>\n<\/jats:sec>\n\nResults<\/jats:title>\nFifty-seven patients (mean age: 12.5 \u00b1 4.9 years; 63% males) were analyzed. Among them, 33 (57.9%) tested positive for anti-CFH antibodies and eight presented postpartum. Initial remission was achieved in 42 (73.6%) patients, with 13 (22.8%) partial and 29 (50.9%) complete remission. The median follow-up duration was 24 months [interquartile range (IQR) 8.5\u201384]; 12 (21%) patients died, with two deaths during the index admission, six among nonresponders, and 4 among responders. Dialysis-free renal survival was superior in anti-CFH seropositive patients (81.2%) compared to seronegative counterparts (55.9%), while patient survival was statistically similar between the two groups. Elevated anti-CFH titers (>4000 AU\/ml), age \u226516 years, female gender, and seizures predicted nonresponsiveness.<\/jats:p>\n<\/jats:sec>\n\nConclusion<\/jats:title>\nAnti-CFH antibody associated aHUS had better kidney outcomes than the seronegative counterparts. In resource limited settings, a combination of plasma exchange and immunosuppression showed promising results in the short and long term.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijn_106_2024","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:14:32Z","timestamp":1723612472000},"page":"402-409","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome"],"prefix":"10.25259","volume":"35","author":[{"given":"Vamsidhar","family":"Veeranki","sequence":"first","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyakumar","family":"Meyyappan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpit","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Shanker","family":"Kushwaha","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas","family":"Behera","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas Ranjan","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupma","family":"Kaul","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmendra Singh","family":"Bhadauria","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Yachha","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai","family":"Kishun","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"10.25259\/IJN_106_2024\/ref-1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12882-022-02746-2","article-title":"Incidence and cost of haemolytic uraemic syndrome in urban China: A national population-based analysis","volume":"23","author":"Feng","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.kint.2018.02.029","article-title":"Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_106_2024\/ref-3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-4","doi-asserted-by":"publisher","first-page":"2054358119897229","DOI":"10.1177\/2054358119897229","article-title":"Clinical characteristics and outcome of Canadian patients diagnosed with atypical hemolytic uremic syndrome","volume":"7","author":"Lapeyraque","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"10.25259\/IJN_106_2024\/ref-5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.25259\/IJN_106_2024\/ref-7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10157-013-0911-8","article-title":"Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the joint committee of the Japanese society of nephrology and the Japan pediatric society","volume":"18","author":"Sawai","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10157-016-1276-6","article-title":"Clinical guides for atypical hemolytic uremic syndrome in Japan","volume":"20","author":"Kato","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","article-title":"Working party from the renal association, the British committee for standards in haematology and the British transplantation society. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom","volume":"148","author":"Taylor","year":"2010","journal-title":"Br J Haematol"},{"key":"10.25259\/IJN_106_2024\/ref-10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: diagnosis and treatment","volume":"35","author":"Campistol","year":"2015","journal-title":"A consensus document. Nefrologia"},{"key":"10.25259\/IJN_106_2024\/ref-11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/imj.13804","article-title":"Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand","volume":"48","author":"Fox","year":"2018","journal-title":"Intern Med J"},{"key":"10.25259\/IJN_106_2024\/ref-12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00467-019-04233-7","article-title":"Hemolytic uremic syndrome in a developing country: Consensus guidelines","volume":"34","author":"Bagga","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int"},{"key":"10.25259\/IJN_106_2024\/ref-14","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fimmu.2019.01282","article-title":"Clinical and immunological profile of anti-factor h antibody associated atypical hemolytic uremic syndrome: A nationwide database","volume":"10","author":"Puraswani","year":"2019","journal-title":"Front Immunol"},{"key":"10.25259\/IJN_106_2024\/ref-15","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.25259\/IJN_106_2024\/ref-16","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.25259\/IJN_106_2024\/ref-17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00467-009-1200-3","article-title":"Hypertension in children and adolescents: Epidemiology and natural history","volume":"25","author":"Falkner","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-18","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.25259\/IJN_106_2024\/ref-19","doi-asserted-by":"publisher","first-page":"1056153","DOI":"10.3389\/fimmu.2022.1056153","article-title":"COVID-19 vaccination and atypical hemolytic uremic syndrome","volume":"13","author":"Bouwmeester","year":"2022","journal-title":"Front Immunol"},{"key":"10.25259\/IJN_106_2024\/ref-20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.idcr.2017.04.004","article-title":"Atypical hemolytic uremic syndrome triggered by varicella infection","volume":"9","author":"Condom","year":"2017","journal-title":"IDCases"},{"key":"10.25259\/IJN_106_2024\/ref-21","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/j.athoracsur.2017.04.008","article-title":"Aortic valve replacement as a trigger of atypical hemolytic uremic syndrome","volume":"104","author":"Markakis","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.25259\/IJN_106_2024\/ref-22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000511833","article-title":"Atypical hemolytic uremic syndrome and nephrotic syndrome associated with cytomegalovirus infection","volume":"145","author":"Duarte","year":"2021","journal-title":"Nephron"},{"key":"10.25259\/IJN_106_2024\/ref-23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12288-013-0262-3","article-title":"Diagnosis and management of atypical hemolytic uremic syndrome in children: Single centre experience","volume":"30","author":"Patel","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.25259\/IJN_106_2024\/ref-24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/imm.12916","article-title":"Characterization of genetic predisposition and autoantibody profile in atypical haemolytic-uraemic syndrome","volume":"154","author":"Gurjar","year":"2018","journal-title":"Immunology"},{"key":"10.25259\/IJN_106_2024\/ref-25","doi-asserted-by":"publisher","first-page":"931210","DOI":"10.3389\/fimmu.2022.931210","article-title":"Anti-factor H antibody and its role in atypical hemolytic uremic syndrome","volume":"13","author":"Raina","year":"2022","journal-title":"Front Immunol"},{"key":"10.25259\/IJN_106_2024\/ref-26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.25259\/IJN_106_2024\/ref-27","doi-asserted-by":"publisher","first-page":"e003573","DOI":"10.1136\/bmjopen-2013-003573","article-title":"A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)","volume":"3","author":"Rathbone","year":"2013","journal-title":"BMJ Open"},{"key":"10.25259\/IJN_106_2024\/ref-28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00467-018-4039-7","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome","volume":"34","author":"Formeck","year":"2019","journal-title":"Pediatr Nephrol"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/indianjnephrol.org\/long-term-outcomes-of-anticomplement-factor-h-antibody-positive-versus-negative-atypical-hemolytic-uremic-syndrome\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/indianjnephrol.org\/long-term-outcomes-of-anticomplement-factor-h-antibody-positive-versus-negative-atypical-hemolytic-uremic-syndrome\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:19:29Z","timestamp":1745576369000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/long-term-outcomes-of-anticomplement-factor-h-antibody-positive-versus-negative-atypical-hemolytic-uremic-syndrome\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":28,"alternative-id":["10.25259\/IJN_106_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijn_106_2024","relation":{},"ISSN":["1998-3662","0971-4065"],"issn-type":[{"type":"electronic","value":"1998-3662"},{"type":"print","value":"0971-4065"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"article-number":"402"}}